ReShape Lifesciences Investor Relations Material
Latest events
Q3 2023
ReShape Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from ReShape Lifesciences Inc
Access all reports
ReShape Lifesciences Inc., a medical device company, develops, manufactures, and markets ReShape Integrated System for the management and treatment of obesity and metabolic diseases. The company offers RHS Gastric Balloon System as a non-surgical alternative to reduce weight; RHI Single Balloon Combination, which is designed to provide a tool to manage diabetes; and RHI Dual Balloon Combination, which is designed to treat conditions associated with obesity such as hypertension, hyperlipidemia, type 2 diabetes mellitus, dyslipidemia and obstructive sleep apnea.
Key slides for ReShape Lifesciences Inc
Investor Presentation
ReShape Lifesciences Inc
Investor Presentation
ReShape Lifesciences Inc
Latest articles
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
John Elkann: Leading Stellantis, Ferrari, and Exor to New Heights
As the Chairman of Stellantis and Ferrari and CEO of Exor, John Elkann is arguably the most influential person in the global automotive sector.
26 Mar 2024
Ticker symbol
Country
🇺🇸 United States